Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Abbreviated, acquiree, AG, agency, analyze, anchored, ANDA, angiotensin, antibiotic, API, Area, arrangement, assembled, asserted, assistance, ATTACK, automatically, aware, bacterial, blood, Book, bore, certification, chargeback, chemical, China, cIAI, CODM, communicated, communication, competing, complicated, comprise, coverage, creation, cumulative, currency, cycle, damaged, demand, dependent, depending, Description, devote, digit, disease, District, double, durlobactam, efficacy, efficiently, EMA, enforce, entry, environment, eravacycline, European, Everest, exclusive, exclusively, exclusivity, Exhibit, fail, failed, fixed, flow, forecast, forecasted, foreclose, foreign, GARDP, George, GIAPREZA, Gland, gonorrhea, GPO, growing, GW, harmed, Harvard, HCR, health, highly, Hong, ICAV, imipenem, indemnify, indirect, Indonesia, Industrial, inflation, Inflationary, infringed, infringement, intellectual, interruption, invalid, inventory, ITH, Jersey, jurisdiction, Kingdom, Kong, Korea, Lab, lapse, large, license, licensed, liquid, listed, longer, low, Macau, mainland, maintain, Maker, Malaysian, manufacture, manufacturing, Medicaid, Medical, mentioned, misconduct, National, NDA, negligence, network, NMPA, noncurrent, North, notice, obsolete, Orange, overhead, owed, PAION, paragraph, Paratek, patent, patient, pertain, Phase, pivotal, point, preclinical, prepayment, pressure, prospective, purpose, quantity, raw, rebate, receipt, recourse, recoverable, region, regulatory, reinforcing, repayment, replaced, replacement, reprioritize, Republic, response, responsible, retroactive, Science, scope, septic, Shanghai, shock, significantly, Singapore, slight, slowdown, Socialist, Society, South, specialty, sublicense, successful, successfully, sum, Summary, supply, Switzerland, Taiwan, Tangible, technology, territory, Thailand, threshold, trial, typically, unable, uncertain, uncomplicated, unenforceable, University, unsuccessful, utilize, valid, variety, vary, varying, version, Vietnam, vigorously, volume, Washington, whichever, workforce, worldwide, write, XERAVA, Zai, ZLAB, zoliflodacin
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view